September 5, 2015
Recommended Topic Related To:

Optison

"SILVER SPRING, MD ” The US Food and Drug Administration (FDA) is warning of several treatment-related serious adverse events in association with implantable left ventricular assist devices (LVADs) in heart-failure patients.

In a "...

Optison

PATIENT INFORMATION

Patients receiving OPTISON should be instructed to inform their healthcare provider if they:

  1. have a congenital heart defect, or recent worsening of heart or lung conditions;
  2. have had reactions to blood, blood products, albumin or a prior OPTISON administration (see CONTRAINDICATIONS and WARNINGS);
  3. may be pregnant or are nursing an infant.

Last reviewed on RxList: 9/6/2012
This monograph has been modified to include the generic and brand name in many instances.

Report Problems to the Food and Drug Administration

 

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


Heart Health

Get the latest treatment options.

Atrial Fibrillation Quiz